By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nucleic acids provider Integrated DNA Technologies said today that it has received a Phase II Small Business Innovation Research grant to continue developing a gene silencing technology project it is developing with a start-up firm called SilaGene.

The new technology uses U1 adapters to down-regulate gene expression at the pre-mRNA stage, which could be used as a method of gene silencing in potential therapeutic technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.